SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
about
HIV type 1 Gag as a target for antiviral therapyCrystallographic and Functional Analysis of the ESCRT-I /HIV-1 Gag PTAP InteractionElucidation of New Binding Interactions with the Human Tsg101 Protein Using Modified HIV-1 Gag-p6 Derived Peptide LigandsUtilization of Nitrophenylphosphates and Oxime-Based Ligation for the Development of Nanomolar Affinity Inhibitors of the Yersinia pestis Outer Protein H (YopH) Phosphatase ‡Identification of High Affinity Polo-like Kinase 1 (Plk1) Polo-box Domain Binding Peptides Using Oxime-Based Diversification4R- and 4S-iodophenyl hydroxyproline, 4R-pentynoyl hydroxyproline, and S-propargyl-4-thiolphenylalanine: conformationally biased and tunable amino acids for bioorthogonal reactions.Novel approaches to inhibiting HIV-1 replication.Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists.Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.N-O linkage in carbohydrates and glycoconjugates.Value of MR contrast media in image-guided body interventions.Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides.Tsg101 chaperone function revealed by HIV-1 assembly inhibitors.Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.
P2860
Q24614498-6F6501F6-36D6-47CB-A9CD-5DBB1A6F9C12Q27665841-D1CFF904-F2EC-45B1-BE7A-2E218055ADF0Q27666254-0923151C-CA8E-4878-819E-A67C33D129E8Q27667338-ADF1A8C3-58F1-4CFC-99DF-E84437FD7E45Q27676966-3FA4C7D0-78A7-4B6D-8FBD-84C984291804Q31039611-496996A7-26B3-459B-B79C-97AA0D54BD3DQ33624690-93CF8787-6595-4A06-A4A6-FDA8DDC64A7AQ33638005-DC0D2F08-4332-493C-A5CC-91EC5FF8EFBEQ34197585-2BD71353-79EE-43F1-8737-C86FEEFEDACCQ35173120-D1806F7E-F637-4CBD-9164-2248AC38539DQ38524164-2F3A89AD-70E9-45B7-BE66-BD215E771706Q38995811-A1BFDB7C-E662-4C05-BD58-93CAD598891FQ39653154-CAE584A7-2EEF-4DF4-B204-934031111BB1Q42928366-79C0327F-7A85-4074-BE60-B0CA2685FBDEQ47105110-6E3292E4-56F4-4778-9C14-9D61ED662F97Q51101229-74C03735-EBC4-488A-8E16-F4DDD1D629D4
P2860
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@ast
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@en
type
label
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@ast
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@en
prefLabel
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@ast
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@en
P2093
P2860
P356
P1433
P1476
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
@en
P2093
Abdul A Waheed
Andrew G Stephen
Eric O Freed
M Javad Aman
Robert J Fisher
Terrence R Burke
P2860
P304
P356
10.1002/CBIC.200800281
P577
2008-08-01T00:00:00Z